Home   Contact Palatin   Site Map  
 

Investor/Media Center

Investor Materials

    Management bios
     

For Institutional Investors and Media:

Carney Noensie
Burns McClellan
(212) 213-0006
cnoensie@burnsmc.com
 
   
          

Press Releases:

Jul-09-2014 Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
 
Jun-27-2014 Palatin Technologies to Join Russell Microcap Index
 
Jun-10-2014 Palatin Technologies Announces Notification of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides
 
May-13-2014 Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on May 13, 2014
 
May-09-2014 Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2014 Results Teleconference and Webcast to be held on May 13, 2014
 
May-06-2014 Palatin Technologies Presents at the American Psychiatric Association (APA)
 
May-01-2014 Palatin Technologies Announces Option Exercise by Specialty Pharmaceutical Company to License Bremelanotide in Europe
 
Apr-29-2014 Palatin Technologies Presents at the Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG)